[ad_1]
The FDA has approved a drug to treat postpartum depression for the first time – here's how it works.
»Subscribe to NowThis: http://go.nowth.is/News_Subscribe
A medication for postpartum depression has been approved by the FDA for the first time. Postpartum depression, a health problem sometimes called baby blues, is a mental health problem that affects many new mothers.
Zulresso is an antidepressant containing the drug brexanolone. which is administered by a continuous intravenous infusion of 60 hours. The FDA says clinical trials have shown that Zulresso can treat the symptoms of postpartum depression within hours.
Postpartum depression affects about 1 in 9 women in the United States and causes symptoms of postpartum depression such as sadness, anxiety and exhaustion. Patients treated with Zulresso had positive effects during the first 24 hours of use and 30 days after the initial IV injection.
The drug is new because it contains a synthetic hormone that increases in the woman's body during pregnancy, then decreases after birth. Zulresso would cost about $ 34,000 per patient for average treatment, and a bottle of Zulresso would cost $ 7,450.
#FDA #Postpartumdepression #Motherhood #Parenting
Sign in with NowThis
Like us on Facebook: http://go.nowth.is/News_Facebook
Twitter on us: http://go.nowth.is/News_Twitter
Follow us on Instagram: http://go.nowth.is/News_Instagram
»Find us on Snapchat Discover: http://go.nowth.is/News_SnClin
NowThis is your main media providing you with all the videos you need to keep up to date with the latest news. From entertainment to politics, to viral videos and the latest news, we provide everything you need to know directly in your social feeds. We live where you live.
http://www.youtube.com/nowthisnews
@nowthisnews
Source link
